These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1442759)

  • 1. Short-term responsiveness of membranous glomerulopathy to cyclosporine.
    Guasch A; Suranyi M; Newton L; Hall BM; Myers BD
    Am J Kidney Dis; 1992 Nov; 20(5):472-81. PubMed ID: 1442759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin and the glomerular filtration barrier in minimal change disease and membranous glomerulopathy.
    Zietse R; Derkx FH; Schalekamp MA; Weimar W
    Contrib Nephrol; 1995; 114():6-18. PubMed ID: 7587200
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
    Heering P; Schneider A; Grabensee B; Plum J
    Dtsch Med Wochenschr; 2001 Oct; 126(40):1093-8. PubMed ID: 11588659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy.
    Ambalavanan S; Fauvel JP; Sibley RK; Myers BD
    J Am Soc Nephrol; 1996 Feb; 7(2):290-8. PubMed ID: 8785399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
    Xu D; Gao X; Bian R; Mei C; Xu C
    Nephrology (Carlton); 2017 Mar; 22(3):251-256. PubMed ID: 28035723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
    Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
    Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproteinuric effect of ciclosporin A in adriamycin nephropathy in rats.
    Desassis JF; Raats CJ; Bakker MA; van den Born J; Berden JH
    Nephron; 1997; 75(3):336-41. PubMed ID: 9069457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte drug sensitivity is useful for prediction of the antiproteinuric effect and relapse rate in cyclosporine treatment for frequent-relapse minimal change nephrotic syndrome.
    Yoshida M; Yoshikawa N; Akashi M; Nakabayashi I; Watanabe T; Iwahori T; Hirano T; Oka K
    Kidney Blood Press Res; 2005; 28(4):226-9. PubMed ID: 16118505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
    Naumovic R; Jovanovic D; Pavlovic S; Stosovic M; Marinkovic J; Basta-Jovanovic G
    Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy.
    Li MX; Yu YW; Zhang ZY; Zhao HD; Xiao FL
    Genet Mol Res; 2015 Mar; 14(1):2665-73. PubMed ID: 25867415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety.
    Yu X; Ruan L; Qu Z; Cui Z; Zhang Y; Wang X; Meng L; Liu X; Wang F; Zhang Y; Liu G; Yang L
    Ren Fail; 2017 Nov; 39(1):688-697. PubMed ID: 28882100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T; Akashi T; Keira T; Oka K; Ihoya N; Yoshida M
    Clin Pharmacol Ther; 2000 Nov; 68(5):532-40. PubMed ID: 11103756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathy.
    Shin DH; Lee MJ; Oh HJ; Koo HM; Doh FM; Kim HR; Han JH; Park JT; Han SH; Choi KH; Yoo TH; Kang SW
    Yonsei Med J; 2013 Jul; 54(4):973-82. PubMed ID: 23709434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.